Cargando…

A latent reactive handle for functionalising heparin-like and LMWH deca- and dodecasaccharides

d-Glucosamine derivatives bearing latent O4 functionality provide modified H/HS-type disaccharide donors for a final stage capping approach enabling introduction of conjugation-suitable, non-reducing terminal functionality to biologically important glycosaminoglycan oligosaccharides. Application to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Gavin J., Broberg, Karl. R., Rudd, Claire, Helliwell, Madeleine R., Jayson, Gordon C., Gardiner, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal Society of Chemistry 2015
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672752/ https://www.ncbi.nlm.nih.gov/pubmed/26381107 http://dx.doi.org/10.1039/c5ob01706h

Ejemplares similares

Tetrasaccharide iteration synthesis of a heparin-like dodecasaccharide and radiolabelling for in vivo tissue distribution studies
por: Hansen, Steen U., et al.
Publicado: (2013)

Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology
por: Jayson, Gordon C., et al.
Publicado: (2015)

Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo
por: Avizienyte, Egle, et al.
Publicado: (2016)

Heparin‐induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review
por: Amdetsion, Gedion Yilma, et al.
Publicado: (2023)

Pulmonary embolism caused by delayed heparin-induced thrombocytopenia in a patient who received prophylactic LMWH
por: Kumar, Mehandar, et al.
Publicado: (2012)

COVID-19 and Diarrhoea: the Therapeutic Role OF LMWH
por: Dioscoridi, Lorenzo, et al.
Publicado: (2021)

Bleeding Risk during Treatment of Acute Thrombotic Events with Subcutaneous LMWH Compared to Intravenous Unfractionated Heparin; A Systematic Review
por: Costantino, Giorgio, et al.
Publicado: (2012)

MON-182 Increased Risk of Bleeding and Excessive Anticoagulation Using Standard Dose Low Molecular Weight Heparin (LMWH) in Cushing’s Syndrome
por: Haykal, Rasha, et al.
Publicado: (2020)

Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres
por: Motlekar, Nusrat, et al.
Publicado: (2009)

The Efficacy of Tripterygium Glycosides Combined with LMWH in Treatment of HSPN in Children
por: Jin, Yan, et al.
Publicado: (2021)

Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
por: Wei, Qingqing, et al.
Publicado: (2023)

Making the longest sugars: a chemical synthesis of heparin-related [4](n) oligosaccharides from 16-mer to 40-mer
por: Hansen, Steen U., et al.
Publicado: (2015)

Low-Molecular-Weight Heparins (LMWH) and Synthetic Factor X Inhibitors Can Impair the Osseointegration Process of a Titanium Implant in an Interventional Animal Study
por: Apostu, Dragos, et al.
Publicado: (2022)

Continuous administration of LMWH in critical patients: a contribution to the monitoring of hemocoagulation
por: Stach, Z, et al.
Publicado: (2006)

Modular Synthesis of Heparin-Related Tetra-, Hexa- and Octasaccharides with Differential O-6 Protections: Programming for Regiodefined 6-O-Modifications
por: Baráth, Marek, et al.
Publicado: (2015)

Low Molecular Weight Heparin (LMWH) Improves Peritoneal Function and Inhibits Peritoneal Fibrosis Possibly through Suppression of HIF-1α, VEGF and TGF-β1
por: Li, Juan, et al.
Publicado: (2015)

Synthesis of a heparin-related GlcN–IdoA sulfation-site variable disaccharide library and analysis by Raman and ROA spectroscopy
por: Miller, Gavin J., et al.
Publicado: (2014)

Comparative Study for Preventive Effects of Intra-Abdominal Adhesion Using Cyclo-Oxygenase-2 Enzyme (COX-2) Inhibitor, Low Molecular Weight Heparin (LMWH), and Synthetic Barrier
por: Kim, Yong Il
Publicado: (2013)

A 3-O-sulfated heparan sulfate dodecasaccharide (12-mer) suppresses thromboinflammation and attenuates early organ injury following trauma and hemorrhagic shock
por: Vidaurre, Maria del Pilar Huby, et al.
Publicado: (2023)

DNA Aptamers for the Functionalisation of DNA Origami Nanostructures
por: Sakai, Yusuke, et al.
Publicado: (2018)

The interaction between oxytocin and heparin
por: Schnur, Einat, et al.
Publicado: (2020)

Enhanced stability and efficacy of GEM-TOS prodrug by co-assembly with antimetastatic shell LMWH-TOS
por: Guo, Rong, et al.
Publicado: (2020)

The effectiveness and safety of LMWH for preventing thrombosis in patients with spinal cord injury: a meta-analysis
por: Lin, Ze, et al.
Publicado: (2021)

Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children
por: Fiamoli, Veronika, et al.
Publicado: (2011)

Coumadin-induced skin necrosis in a 64 year-old female despite LMWH bridging therapy
por: Kumar, Mehandar, et al.
Publicado: (2012)

Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?
por: Kucukoner, Mehmet, et al.
Publicado: (2012)

CLRM-03 INCIDENCE OF INTRACRANIAL HEMORRHAGE IN GLIOMA PATIENTS WITH VENOUS THROMBOEMBOLISM CONVERTED FROM LMWH TO APIXABAN
por: Aboud, Orwa, et al.
Publicado: (2022)

A comparison of performance of Deca Iron and Triple Deca Iron ultra-triathletes
por: Knechtle, Beat, et al.
Publicado: (2014)

Editorial: Heparin and Related Polysaccharides
por: Gray, Elaine, et al.
Publicado: (2020)

Effect of Functionalised and Non-Functionalised Carbon Nanotubes-Urea Fertilizer on the Growth of Paddy
por: Yatim, Norazlina Mohamad, et al.
Publicado: (2018)

Advances in the synthesis of functionalised pyrrolotetrathiafulvalenes
por: O’Driscoll, Luke J, et al.
Publicado: (2015)

Targeting of Basophil and Mast Cell Pro-Allergic Reactivity Using Functionalised Gold Nanoparticles
por: Yasinska, Inna M., et al.
Publicado: (2019)

Potassium decaborate monohydrate
por: Gao, Yi-Hong
Publicado: (2011)

Rigidochromism by imide functionalisation of an aminomaleimide fluorophore
por: Husband, Jonathan T., et al.
Publicado: (2021)

Heparin-induced hyponatremia in COVID-19: A latent culprit!
por: Panda, Rajesh, et al.
Publicado: (2021)

Pillararene-functionalised graphene nanomaterials
por: Zhang, Huacheng, et al.
Publicado: (2020)

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit
por: Vlot, E.A., et al.
Publicado: (2020)

DOACs or VKAs or LMWH – What is the optimal regimen for cancer-associated venous thromboembolism? A systematic review and meta-analysis
por: Yamani, Naser, et al.
Publicado: (2022)

Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing?
por: Diepstraten, Jeroen, et al.
Publicado: (2022)

Thrombin Generation Decrease After LMWH Administration in an Antithrombin-Deficient Pregnant Woman With a Homozygous HBS II Mutation
por: Malikova, Ivana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_imcenetake11ha916iohovgbo9